We examine benefits and risks of vasopressin/terlipressin use in patients with vasodilatory shock on mortality and morbidity.
No takes yet. Share an insight, caveat, or question.
Polito et al. (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: